Peptides in skincare: GHK-Cu, Matrixyl and Argireline in studies
In short
Skincare peptides such as GHK-Cu, Matrixyl and Argireline are cosmetic ingredients in creams and serums whose human studies are small and mixed [1] [4]A [8]B. A cream study says nothing about injecting [10]regulator.
- In a 12-week study of palmitoyl pentapeptide-4 (Matrixyl) in 93 women, wrinkles decreased more on the peptide side [4]A.
- In an independent study of acetyl hexapeptide-8 (Argireline) there was no difference [8]B.
- Human studies of GHK-Cu are mostly small facial cream studies, and about 35% of original GHK-Cu studies come from the same commercially linked group [1].
- Under the EU Cosmetics Regulation an injected substance is not a cosmetic [10]regulator. GHK-Cu is in Annex 1 A of Fimea's medicines list, whose substances are treated like prescription-only medicines, but according to the list not every product containing it is a medicine [12]regulator.
What are skincare peptides?
Peptides are short chains of amino acids. In skincare they are used in creams and serums applied to the skin. Under the EU Cosmetics Regulation, a cosmetic product is intended for the external parts of the human body, such as the skin, for example to clean, protect, change the appearance of or keep it in good condition [10]regulator.
- GHK-Cu is the copper complex of the human three-amino-acid peptide GHK [2]. It has its own page: GHK-Cu.
- Palmitoyl pentapeptide-4, or Matrixyl (pal-KTTKS), is a five-amino-acid peptide linked to a fatty acid that was thought to increase collagen production [4]A.
- Acetyl hexapeptide-8, or Argireline, is a six-amino-acid peptide designed to mimic the action of botulinum toxin [6]D. The same peptide has also been called acetyl hexapeptide-3 [5].
Basics: What are peptides?. All substances: Peptides A-Z.
The skin also makes its own antimicrobial peptides, such as the skin’s own LL-37.
Melanotan 1, or afamelanotide, which acts on skin pigment, is not a skincare product but a medicine: its approved form is an implant placed by a doctor.
Evidence at a glance
Each cell gives the kind of study and its source. The letter is the evidence level, not the result.
| Claimed effect | Humans | Animals | Cells |
|---|---|---|---|
| Wrinkles, Matrixyl (palmitoyl pentapeptide-4) | 93 women, 12 weeks, wrinkles decreased [4]A; 21 women, preliminary [5]A | - | - |
| Wrinkles, Argireline (acetyl hexapeptide-8) | Chinese study: an effect [7]A; independent study: no difference [8]B | - | Inhibited neurotransmitter release, much less than botulinum toxin [6]D |
| Skin after laser treatment, GHK-Cu | 13 patients: evaluators saw no difference, patients more satisfied [3]A | - | - |
| Collagen production, GHK-Cu | Mostly small cream studies [1] | Decades of animal studies [1]C | Increased collagen and elastin production in cells [2]D |
| Safety | Creams well tolerated in small studies [4]A [8]B; rare harms cannot be detected [1] | - | - |
"-" = no such study is known.
What are skincare peptides used for?
Skincare peptides are used in cosmetics to reduce wrinkles and other signs of skin ageing. They are cosmetic ingredients, not medicines [10]regulator.
- Wrinkles and lines: Matrixyl and Argireline creams [4, 5, 7]A [8]B.
- Skin care after a procedure: GHK-Cu after laser treatment [3]A.
- Microneedle patches: a combination product with several peptides [9]B.
Claims online. Online, Argireline is called "Botox in a cream". In the laboratory it was much less effective than botulinum toxin [6]D, and an independent cream study did not show an effect on wrinkles [8]B. See also the guide Collagen and peptides for skin.
How do skincare peptides work?
Each skincare peptide has its own proposed mechanism, described mainly in the laboratory.
- GHK-Cu: Pickart's review describes many effects of GHK, such as increased collagen and elastin production, and explains them with gene data [2]D. Pickart has had commercial interests in the field [1].
- Matrixyl: it was thought to increase collagen production [4]A.
- Argireline: in the laboratory it inhibited neurotransmitter release, but much less effectively than botulinum toxin [6]D.
It is not known how much of a cream is absorbed into the skin for these mechanisms to work. Even GHK-Cu delivered with microneedles has not been tested in an adequately powered human trial [1].
Have skincare peptides been studied in humans?
Yes, but the studies are small and short, some are linked to manufacturers, and results vary [1] [4, 5]A [8]B.
GHK-Cu
A 2026 systematic review screened 1,247 records and kept 64. Randomised human trials are mostly small studies of facial creams [1]. In a small randomised study, skin around the mouth treated with a CO2 laser was cared for with products with or without GHK-Cu. Thirteen patients completed the study. Blinded evaluators found no difference in improvement of wrinkles or skin quality, but patient-rated satisfaction was higher in the GHK-Cu group (P = .04) [3]A.
Matrixyl (palmitoyl pentapeptide-4)
- Robinson 2005. In a 12-week double-blind study, 93 Caucasian women aged 35-55 used a moisturiser containing palmitoyl pentapeptide on one side of the face and the same moisturiser without it on the other. Wrinkles and fine lines decreased more on the peptide side by both image analysis and expert graders. The first author worked for the cosmetics company Procter & Gamble [4]A.
- Aruan 2023. In an eight-week double-blind study, 21 Indonesian women aged 26-55 were divided into three groups: acetyl hexapeptide-3 cream, palmitoyl pentapeptide-4 cream or placebo cream. Wrinkles around the eyes improved in some participants, and palmitoyl pentapeptide-4 appeared to work better. The authors called the study preliminary. The study was funded by the Indonesian company Paragon Technology and Innovation [5]A.
Argireline (acetyl hexapeptide-8)
- Blanes-Mira 2002. Healthy women used an emulsion containing hexapeptide for 30 days, and wrinkle depth decreased by up to 30% [6]B. According to a later article there were ten participants, and the base emulsion alone reduced wrinkle depth by up to 10% [6]B [8].
- Wang 2013. In a Chinese study, 60 people received Argireline or placebo in a 3:1 ratio for four weeks. By subjective assessment, 48.9% of the Argireline group and none of the placebo group showed an effect, and skin roughness measures decreased in the Argireline group [7]A.
- Henseler 2023, negative result. In a four-week double-blind study, 19 women used a serum where only the serum for one side of the face contained Argireline. The article does not say whether the side was randomised. Camera-measured wrinkle scores did not differ between the sides (p = 0.829). The author declared no competing interests [8]B.
SNAP-8 (acetyl octapeptide-3)
The only human study with SNAP-8 tested a combination product. Its microneedle patch contained several peptides and other substances, and the study ran at one centre for 12 weeks. The abstract does not mention a comparison group, so the effect of a single ingredient cannot be separated [9]B.
Promising, but only in animal and cell studies
The broadest claims for GHK-Cu rest on cell and animal studies that have not been repeated in adequately powered human trials [1].
-
GHK-Cu and tissue renewal no human studies
According to the review, GHK-Cu has decades of cell and animal studies [1]C. Pickart's review describes GHK increasing collagen and elastin production in the laboratory, among other effects [2]D.
If it held in humans: GHK-Cu applied to or delivered into the skin could support skin repair.
Why it might not translate: about 35% of GHK-Cu studies come from the same commercially linked group [1], and in humans the blinded evaluators of the laser study saw no difference [3]A.
Evidence now: according to the review, GHK-Cu delivered with microneedles has not been tested in a single registered, adequately powered human trial [1].
Who studies skincare peptides?
Many studies are linked to companies in the field.
- About 35% of original GHK-Cu studies list Loren Pickart or Anna Margolina (Skin Biology Inc.) as an author, and Pickart has held commercial interests in the field for decades. The review says this limits the independence of the evidence [1].
- The first author of the Matrixyl study worked for a cosmetics company [4]A, and the Indonesian study was funded by a company [5]A.
- In the independent Argireline study, the author declared no competing interests, and no effect was shown [8]B.
Who wrote this page: the editorial team
This page was written by the Molecular Recovery editorial team. The draft was made with the help of AI, and the claims were checked against the sources (AI policy). The page has not been medically reviewed. How we work: About us.
What are the side effects of skincare peptides?
In small studies the peptide creams were well tolerated, but the studies are too small to detect rare harms [1] [4]A [8]B. In users' accounts (not research), however, 13 of 35 people who used a copper peptide cream or serum and 17 of 49 who used another peptide cream or serum reported a harm. The accounts are collected on the page Collagen and skin peptide user experiences. They are self-selected and do not show how common the harms are.
Creams and serums
The Matrixyl cream was well tolerated in the study [4]A. In the Argireline serum study, the 19 participants had no significant adverse events, allergic reactions or skin irritation [8]B, and no skin reactions were reported in the microneedle patch study [9]B. Under the Cosmetics Regulation, a cosmetic product on the market must be safe when used under normal or reasonably foreseeable conditions [10]regulator.
Injecting is a different matter
According to Fimea, the possible harms of injectable products bought online may be unknown, and impurities such as endotoxins can cause serious harm to health [11]regulator. More: Side effects and safety.
Interactions and who has no data
We know of no published human study of interactions with other skincare products or medicines. The studies included mostly adult women [4, 5]A [8]B, so there are fewer data on other groups.
Evidence against and what is unknown
The most independent study was negative [8]B, and positive results often come from researchers linked to manufacturers [1] [4, 5]A.
Evidence against
- In an independent study the effect of Argireline was not shown (p = 0.829) [8]B.
- In the GHK-Cu laser study, blinded evaluators saw no difference [3]A.
- In the first Argireline study, the base emulsion alone reduced wrinkle depth by up to 10% [6]B [8].
What the evidence does not support
- "Argireline is like Botox in a cream": in the laboratory it was much less effective than the toxin [6]D, and an independent cream study did not show an effect [8]B.
- "A peptide cream result also applies to an injected peptide": it does not. The studies concern products applied to the skin, and an injected substance is not a cosmetic [10]regulator.
- "The skin benefits of GHK-Cu have been shown in humans": human studies are mostly small facial cream studies [1], and in a laser study evaluators saw no difference [3]A.
What is not known
- Whether GHK-Cu works when delivered into the skin with microneedles [1].
- Whether the Matrixyl benefit holds up in larger studies. The authors of the Indonesian study asked for a larger and longer follow-up [5]A.
- What SNAP-8 does on its own. The only human study tested a combination product [9]B.
- Rare harms. The studies are too small to detect them [1].
Skincare peptide concentrations in studies
There is no approved dosing, because these are cosmetic ingredients, not medicines [10]regulator. Below are the conditions of the cream studies. They are not instructions.
| Study | Who | Dose and route | Duration |
|---|---|---|---|
| Robinson 2005 (Matrixyl) | 93 women | moisturiser with 3 ppm palmitoyl pentapeptide, on the face | 12 weeks [4]A |
| Blanes-Mira 2002 (Argireline) | 10 healthy women (number from a later article [8]) | emulsion with 10% hexapeptide, on the skin | 30 days [6]B |
| Wang 2013 (Argireline) | 60 people | cream on the skin twice daily | 4 weeks [7]A |
| Aruan 2023 (Matrixyl and Argireline) | 21 women | cream on the skin twice daily | 8 weeks [5]A |
What the numbers do not tell you. The abstract of the GHK-Cu laser study does not give a concentration [3]A. Nothing can be concluded from cream studies about an injected amount, because an injected substance is not a cosmetic [10]regulator. A fuller table with sources: Skincare peptide concentrations in studies. Why the vial calculator does not cover these substances: skincare peptides and the calculator.
Argireline vs botulinum toxin: what is the difference?
They are different substances. Argireline was designed to mimic the action of botulinum toxin, but in the laboratory it inhibited neurotransmitter release much less effectively than the toxin [6]D.
Argireline is an ingredient of creams applied to the skin [7]A [8]B. In an independent study its effect on wrinkles was not shown [8]B.
Combinations and blends
Creams on sale often contain several peptides together. In the combination product study, the abstract mentions no comparison group, so the effect of a single ingredient cannot be separated [9]B.
Sellers also declare GHK-Cu as a component of the injectable GLOW blend sold online. Cream studies say nothing about such a product [10]regulator. More: Peptide blends: what is in the vial and why the seller's label is not enough.
Are skincare peptides legal in Finland?
Yes: as creams and serums, skincare peptides are cosmetics governed by the EU Cosmetics Regulation [10]regulator. An injectable product is a different matter [10, 11]regulator.
- Cosmetics Regulation. Under Regulation (EC) No 1223/2009, a substance intended to be ingested, inhaled, injected or implanted is not a cosmetic product. The responsible person must ensure before placing a product on the market that it has undergone a safety assessment [10]regulator.
- Medicines list. GHK-Cu is listed in Annex 1 A of Fimea's medicines list (230/2025) [12]regulator. Annex 1 A substances are controlled as medicines in Finland and are always treated like prescription-only medicines. According to the list, however, not every product containing a listed substance is necessarily a medicine: a product is assessed on its presentation, composition and use, among other things [12]regulator.
- Fimea warning. On 29 June 2026 Fimea warned about injectable peptides bought online or through social media. According to Fimea, a product injected through the skin may be a medicine in Finland, and a "for research use only" label means the product is not intended for humans [11]regulator. More: Peptides and the law.
This is not legal advice. Disclaimer.
How to assess a skincare peptide product
Check who did and funded the study: many studies are linked to companies in the field [1] [4, 5]A, and in an independent study the effect of Argireline was not shown [8]B.
According to Fimea, an unauthorised product sold online may contain a different substance than the label says, and for injectables impurities such as endotoxins are a particular risk [11]regulator. A cream study result says nothing about the quality of powder sold for injection. On certificates of analysis (COA): How to read a COA and check a test result.
FAQ
Peptides in skincare: do they work?
Not known for certain. In a Matrixyl study wrinkles decreased [4]A, but in an independent Argireline study there was no difference [8]B.
Peptide cream experiences: what can they tell you?
Users' accounts of peptide creams and serums are collected on the page Collagen and skin peptide user experiences. The accounts are not research. In studies the creams were well tolerated, but results on wrinkles varied [4]A [8]B.
GHK-Cu serum: is there evidence?
Little. Human studies are mostly small facial cream studies [1]. In a laser study evaluators saw no difference, although patients were more satisfied [3]A.
Argireline vs Botox: is acetyl hexapeptide-8 the same as botulinum toxin?
No. Argireline was designed to mimic botulinum toxin, but in the laboratory it was much less effective [6]D, and an independent study did not show an effect [8]B.
Matrixyl (palmitoyl pentapeptide-4): what does the research show?
In a 12-week study in 93 women, wrinkles decreased more with the peptide cream than without it. The first author worked for a cosmetics company [4]A.
Peptide cream vs injection: what is the difference?
They are different things. The studies concern products applied to the skin, and an injected substance is not a cosmetic [10]regulator. Fimea warns against injectable peptides bought online [11]regulator.
Read the research yourself: sources
Every source opens the original publication or the regulator's page. The level shows what the source itself reports.
- Najafi N, Maatouk H, Vardanyan KG, et al. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. Arch Intern Med Res. 2026;9(3):269-293. PMID 42787770 (review)
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID 29986520 (review)
- Miller TR, Wagner JD, Baack BR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9. PMID 16847171 A
- Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-60. PMID 18492182 A
- Aruan RR, Hutabarat H, Widodo AA, et al. Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet. J Clin Aesthet Dermatol. 2023;16(2):37-43. PMID 36909866 A
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24(5):303-10. PMID 18498523 B
- Wang Y, Wang M, Xiao S, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013;14(2):147-53. PMID 23417317 A
- Henseler H. Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia Complexion Analysis camera system for objective skin analysis. GMS Interdiscip Plast Reconstr Surg DGPW. 2023;12:Doc09. PMID 38024099 B
- Avcil M, Akman G, Klokkers J, et al. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study. J Cosmet Dermatol. 2020;19(2):328-337. PMID 31134751 B
- Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products, Articles 2, 3 and 10 (Official Journal copy hosted by the European Commission). European Commission regulator
- Fimea. Fimea warns: do not use injectable peptides purchased online (29 Jun 2026). Fimea regulator
- Finland. Lääkeluettelo (Fimea medicines list), 230/2025, section 1 and annex 1 A. Finlex regulator
Research sources checked 12 Oct 2026. Regulator and registry sources checked 15 Sep to 12 Oct 2026.
Evidence levels: A = randomised human trial or meta-analysis · B = observational human study or case series · C = animal study · D = cell or laboratory study · E = not peer-reviewed · regulator = a regulator's assessment or decision, not research evidence. The marker official means official product information (summary of product characteristics or label); it is not research evidence. For a review, the level shows what kind of research the statement rests on. No level: statements that something has not been studied, reviews' interpretations, named hypotheses and the general rules in our certificate-of-analysis guide.
Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.